Comparative Survey of People with ME/CFS in Italy, Latvia, and the UK: A Report on Behalf of the Socioeconomics Working Group of the European ME/CFS Research Network (EUROMENE). — CFSMEATLAS
Comparative Survey of People with ME/CFS in Italy, Latvia, and the UK: A Report on Behalf of the Socioeconomics Working Group of the European ME/CFS Research Network (EUROMENE).
Brenna, Elenka, Araja, Diana, Pheby, Derek F H · Medicina (Kaunas, Lithuania) · 2021 · DOI
Quick Summary
Researchers surveyed people with ME/CFS in Italy, Latvia, and the UK to understand how the disease affects their lives and finances. They found that ME/CFS has a serious impact on income and quality of life across all three countries, and that graded exercise therapy (a treatment commonly used in the UK) did not work for patients. The study also revealed differences in how doctors diagnose and treat ME/CFS depending on which country people live in.
Why It Matters
This study provides evidence that ME/CFS has consistent, serious impacts on patients' finances and well-being across different European healthcare systems, which supports the need for policy changes and better medical recognition. The finding that graded exercise therapy is ineffective challenges a treatment approach that has been widely recommended, potentially influencing clinical practice guidelines. Understanding these cross-national patterns helps identify what works and what doesn't in ME/CFS care.
Observed Findings
Graded exercise therapy was reported as universally ineffective across all respondents who tried it.
Household income impacts from ME/CFS were similar and substantial across all three countries.
Patients in all three countries reported significant difficulties explaining their illness to doctors.
Demographic characteristics of ME/CFS patients were similar across Italy, Latvia, and the UK.
Illness progression and medical management patterns differed significantly between the three countries, possibly reflecting different healthcare systems and societal attitudes.
Inferred Conclusions
ME/CFS has a consistent and severe socioeconomic impact on patients regardless of geographic location or healthcare system.
Current approaches to ME/CFS diagnosis and management vary significantly between countries and may not reflect best practices.
Graded exercise therapy, despite being practiced in the UK, does not benefit ME/CFS patients and may need to be reconsidered in clinical guidelines.
Healthcare providers across all three countries have insufficient understanding of ME/CFS, leading to patient difficulty in obtaining recognition and appropriate care.
Remaining Questions
Why does graded exercise therapy fail, and what alternative treatments might be more effective for ME/CFS patients?
What This Study Does Not Prove
This survey cannot establish cause-and-effect relationships or explain why graded exercise therapy failed—it only documents patient-reported experiences. The findings reflect patient perceptions and self-reported outcomes rather than objective clinical measurements. Differences between countries may reflect variations in how patients accessed care, their healthcare literacy, or reporting bias rather than true differences in disease presentation.
What specific differences in healthcare systems and societal attitudes between the three countries explain variations in disease management patterns?
How do patient-reported outcomes compare to objective clinical measures of disease severity and progression?
What policy interventions would most effectively improve diagnosis, care, and financial support for ME/CFS patients across different healthcare systems?